Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness
NCT06607237
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DEVICE:
DM-28
Sponsor
Horus Pharma
Collaborators
[object Object]